Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>PROTEIN C

PROTEIN C

PROTEIN C Structure
PROTEIN C structure
CAS No.
60202-16-6
Chemical Name:
PROTEIN C
Synonyms
APC;PROTEIN C;APC, HUMAN;HUMAN PROTEIN C;PROTEIN C, HUMAN;Drotrecogin Alfa;PROTEIN C SOLUTION;PROTEIN C, ACTIVATED;PROTEIN C, HUMAN PLASMA;PROTEIN C CONTROL PLASMA
CBNumber:
CB4469636
Molecular Formula:
C33H38N4O8
Molecular Weight:
0
MDL Number:
MFCD00165567
MOL File:
Mol file
Last updated:2023-04-23 13:52:06
Request For Quotation

PROTEIN C Properties

Melting point 166-168°C
storage temp. −20°C
solubility H2O: 1 mg/mL
form lyophilized powder
color Pale Yellow to Light Yellow
FDA UNII 3Z6S89TXPW

SAFETY

Risk and Safety Statements

Hazard Codes  B
Safety Statements  36/37
WGK Germany  3
HS Code  3504009000

PROTEIN C price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
American Custom Chemicals Corporation API0007520 DROTRECOGIN ALFA 95.00% 60202-16-6 0.1MG $881.84 2021-12-16 Buy
American Custom Chemicals Corporation API0007520 DROTRECOGIN ALFA 95.00% 60202-16-6 1G $1024.78 2021-12-16 Buy
American Custom Chemicals Corporation API0007520 DROTRECOGIN ALFA 95.00% 60202-16-6 5G $1837.32 2021-12-16 Buy
American Custom Chemicals Corporation API0007520 DROTRECOGIN ALFA 95.00% 60202-16-6 10G $2765.07 2021-12-16 Buy
Product number Packaging Price Buy
API0007520 0.1MG $881.84 Buy
API0007520 1G $1024.78 Buy
API0007520 5G $1837.32 Buy
API0007520 10G $2765.07 Buy

PROTEIN C Chemical Properties,Uses,Production

Chemical Properties

Pale Yellow Solid

Uses

A major metabolite of Irinotecan

General Description

Drotrecogin alfa (activated), drotrecoginalfa (activated; Xigris), is a recombinant form of humanactivated protein C. Activated protein C exerts an antithromboticeffect by inhibiting factors Va and VIIIa. In vitro dataindicate that activated protein C has indirect profibrinolyticactivity through its ability to inhibit plasminogen activator inhibitor-1 (PAI-1) and to limit generation of activated thrombin-activatable fibrinolysis inhibitor. Additionally, in vitrodata indicate that activated protein C may exert an antiinflammatoryeffect by inhibiting TNF production by monocytes,by blocking leukocyte adhesion to selectins, and bylimiting the thrombin-induced inflammatory responses withinthe microvascular epithelium.Vials of drotrecogin alfa should be stored at 2°C to 8°Cwithout freezing. The reconstituted solution is stable for14 hours at 25°C.

PROTEIN C Preparation Products And Raw materials

Raw materials

Preparation Products

PROTEIN C Suppliers

Global( 57)Suppliers
Supplier Tel Email Country ProdList Advantage
Career Henan Chemica Co 		+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
Beijing HuaMeiHuLiBiological Chemical 010-56205725 waley188@sohu.com China 12338 58
Shanghai Yaji Biological Technology Co., Ltd. 021-34661275 15301693058 yajikit@163.com China 6633 58
Shanghai Yingxin Laboratory Equipment Co., Ltd. 021-021-59178156 17002132182 3146474380@qq.com China 11610 58
United States Biological -- sales@advtechind.com United States 6106 58
Supplier Advantage
Career Henan Chemica Co 		58
Beijing HuaMeiHuLiBiological Chemical 58
Shanghai Yaji Biological Technology Co., Ltd. 58
Shanghai Yingxin Laboratory Equipment Co., Ltd. 58
United States Biological 58

60202-16-6(PROTEIN C)Related Search:

Amyloid β-Protein (1-42) (mouse, rat) AMYLOID BETA-PROTEIN (HUMAN, 25-35) TRIFLUOROACETATE,AMYLOID BETA-PROTEIN FRAGMENT 25-35 AMYLOID BETA-PROTEIN FRAGMENT 1-38 AMYLOID BETA-PROTEIN (HUMAN, 1-42) TRIFLUOROACETATE AMYLOID-BETA-PROTEIN FRAGMENT 1-40, ALL D-AMINO ACIDS
ANNEXIN V, APC AMYLOID BETA-PROTEIN (HUMAN, 1-16),AMYLOID BETA-PROTEIN [GLN11]-FRAGMENT 1-16 AMYLOID DAN PROTEIN PRECURSOR277 (244-277),AMYLOID DAN PROTEIN FRAGMENT 1-34,AMYLOID DAN PROTEIN (1-34) AMYLOID BETA-PROTEIN FRAGMENT 22-35 AMYLOID DAN PROTEIN PRECURSOR277 (244-277) (REDUCED),AMYLOID DAN PROTEIN (1-34) (REDUCED)
AMYLOID BETA-PROTEIN FRAGMENT 1-43 AMYLOID BRI PROTEIN PRECURSOR 227 FRAGMENT 89-106 AMYLOID BRI PROTEIN PRECURSOR 277 (244-266),AMYLOID BRI PROTEIN (1-23),AMYLOID BRI PROTEIN FRAGMENT 1-23 AMYLOID BETA-PROTEIN (HUMAN, 1-43) TRIFLUOROACETATE,AMYLOID BETA-PROTEIN (HUMAN, 1-40) TRIFLUOROACETATE 125I-PROTEIN G BOLTON-HUNTER LABELED
AMYLOID BETA-PROTEIN FRAGMENT 35-25 AMYLOID B-PROTEIN FRAGMENT 17-40 AMYLOID BETA-PROTEIN FRAGMENT 40-1

1of4

PROTEIN C SOLUTION Recombinant Human Activated Protein C 4-[(4-Carboxybutyl)amino]-1-piperidinecarboxylic Acid (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester 7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin Drotrecogin Alfa ACTIVATED HUMAN PROTEIN C PROTEIN C, ACTIVATED, HUMAN PLASMA PROTEIN C, HUMAN PROTEIN C CONTROL PLASMA PROTEIN C, HUMAN PLASMA PROTEIN C, ACTIVATED, HUMAN PROTEIN C, ACTIVATED PROTEIN C HUMAN PROTEIN C APC APC, HUMAN HUMAN PROTEIN C, FROM PLASMA TIGIT (T Cell Immunoreceptor with Ig ITIM Domains, VSIG9, VSTM3, WUCAM)  EasyComp Fluorescent Particles Kit, 5 vials (Blank, FITC, PE, PE-Cy5 & 60202-16-6 C33H38N4O8 Proteolytic Enzymes and Substrates Proteolytic Enzymes Enzymes, Inhibitors, and Substrates Biochemicals and Reagents BioChemical enzyme Intermediates & Fine Chemicals Metabolites & Impurities Pharmaceuticals